We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Joovvin' for Your Skin Health Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04471896
Recruitment Status : Completed
First Posted : July 15, 2020
Last Update Posted : February 12, 2021
Information provided by (Responsible Party):

Brief Summary:
Sixty day single arm trial examining self-report and remote dermatology assessment of cosmetic skin health after daily 10-20 minute sessions with an infrared light therapy device (the Joovv Mini)

Condition or disease Intervention/treatment Phase
Skin Inflammation Acne Skin Diseases Dermatological Non-Disease Skin Condition Eczema Device: Joovv Mini Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 63 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Examining the Impact of Infrared Light Therapy Device on Cosmetic Skin Health
Actual Study Start Date : August 1, 2020
Actual Primary Completion Date : December 31, 2020
Actual Study Completion Date : February 1, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cosmetics

Arm Intervention/treatment
Experimental: Treatment Arm
Participants will receive an infrared therapy device for use at home for 60 days. Participants will use the device every day for 10-20 minutes during the intervention period.
Device: Joovv Mini
Infrared light therapy uses certain wavelengths of light that are delivered to the face. This study will use the Joovv Mini.
Other Name: Infrared light therapy device

Primary Outcome Measures :
  1. Blinded Dermatology Assessment of Facial Skin Health [ Time Frame: 60 day ]
    Comparison over timepoints of physician assessment of facial features at rest and smile to the Glogau & custom wrinkle selfie scale

  2. Changes in Self-Report Skin, Hair & Nail Health and Satisfaction [ Time Frame: 60 day ]
    A custom self report survey on cosmetic skin health satisfaction

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • willingness to use device for 60 days
  • willingness to place security deposit on device of $149.99
  • US resident with an address than can accept UPS deliveries
  • 18 years old
  • no serious medical conditions
  • no medically treatable skin diseases
  • willingness to take a selfie with mobile phone

Exclusion Criteria:

  • Retinoid use
  • prior use of light therapy within the past 6 months
  • pregnant or nursing
  • dietary supplements for skin, hair or nail health

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04471896

Layout table for location information
United States, New York
ProofPilot (Virtual Study: https://p.proofpilot.com)
New York, New York, United States, 10003
Sponsors and Collaborators
Layout table for additonal information
Responsible Party: ProofPilot
ClinicalTrials.gov Identifier: NCT04471896    
Other Study ID Numbers: 2521
First Posted: July 15, 2020    Key Record Dates
Last Update Posted: February 12, 2021
Last Verified: February 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Skin Diseases
Pathologic Processes